HUT38263A - Process for rendering active substances soluble and production of therapeutic compositions comprising these substances - Google Patents

Process for rendering active substances soluble and production of therapeutic compositions comprising these substances

Info

Publication number
HUT38263A
HUT38263A HU851440A HU144085A HUT38263A HU T38263 A HUT38263 A HU T38263A HU 851440 A HU851440 A HU 851440A HU 144085 A HU144085 A HU 144085A HU T38263 A HUT38263 A HU T38263A
Authority
HU
Hungary
Prior art keywords
substances
production
therapeutic compositions
soluble
active substances
Prior art date
Application number
HU851440A
Other languages
English (en)
Other versions
HU195918B (en
Inventor
Jerome Corbiere
Original Assignee
Jerome Corbiere
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jerome Corbiere filed Critical Jerome Corbiere
Publication of HUT38263A publication Critical patent/HUT38263A/hu
Publication of HU195918B publication Critical patent/HU195918B/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
HU851440A 1984-03-14 1985-03-12 Process for producing pharmaceutical compositions containing non-steroide antiflogistic active components HU195918B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH127984 1984-03-14
PCT/FR1985/000050 WO1985004106A1 (fr) 1984-03-14 1985-03-12 Ppocede de solubilisation de principes actifs et compositions pharmaceutiques ainsi obtenues

Publications (2)

Publication Number Publication Date
HUT38263A true HUT38263A (en) 1986-05-28
HU195918B HU195918B (en) 1988-08-29

Family

ID=4206704

Family Applications (1)

Application Number Title Priority Date Filing Date
HU851440A HU195918B (en) 1984-03-14 1985-03-12 Process for producing pharmaceutical compositions containing non-steroide antiflogistic active components

Country Status (12)

Country Link
US (1) US4794117A (hu)
EP (1) EP0173729B1 (hu)
JP (1) JPS61501566A (hu)
KR (1) KR930000029B1 (hu)
AT (1) ATE57472T1 (hu)
AU (1) AU573321B2 (hu)
DE (1) DE3580140D1 (hu)
HU (1) HU195918B (hu)
IT (1) IT1200410B (hu)
NO (1) NO165626C (hu)
OA (1) OA08170A (hu)
WO (1) WO1985004106A1 (hu)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607662D0 (en) * 1986-03-27 1986-04-30 Rainsford K D Pharmaceutical formulation
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US5110493A (en) * 1987-09-11 1992-05-05 Syntex (U.S.A.) Inc. Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
DK174702B1 (da) * 1987-09-11 2003-09-29 Syntex Llc Konserveringssystem til ophthalmiske formuleringer
US5290774A (en) * 1989-08-03 1994-03-01 Eisai Co., Ltd. Photostabilizing method for ophthalmic solutions and the resulting ophthalmic solutions therefrom
DK0436726T3 (da) * 1989-08-03 1993-12-27 Eisai Co Ltd Fotostabil oftalmisk opløsning og fremgangsmåde til fremstilling deraf
DE4342907A1 (de) * 1993-12-16 1995-06-22 Bayer Ag Neue cyclische Depsipeptide mit 18 Ringatomen und ihre Verwendung zur Bekämpfung von Endoparasiten
BR9508655A (pt) * 1994-09-01 1997-08-12 Upjohn Co Composição farmacêutica aquosa estéril
US6274592B1 (en) * 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
US6844004B2 (en) * 1997-08-15 2005-01-18 Board Of Regents, The University Of Texas System Topical formulations of natamycin/pimaricin
US6045815A (en) * 1997-08-15 2000-04-04 Board Of Regents, The University Of Texas System Parenteral pimaricin as treatment of systemic infections
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US6387400B1 (en) 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
ITMI20012135A1 (it) 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
FR2851164B1 (fr) 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
JP2009510007A (ja) * 2005-09-30 2009-03-12 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む医薬調製
CN101909601B (zh) * 2008-01-18 2013-06-26 陶氏环球技术公司 使用甲氧基聚乙二醇增强难溶性活性剂的水溶解度的方法
JP4959006B2 (ja) * 2009-02-03 2012-06-20 サンスター株式会社 ヘスペリジン含有組成物
CN102647971B (zh) 2009-10-12 2016-03-16 贝林格尔.英格海姆维特梅迪卡有限公司 用于包含美洛昔康的组合物的容器
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
AU2010347598B2 (en) 2010-03-03 2014-11-27 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
US20120022149A1 (en) * 2010-07-21 2012-01-26 Chowhan Masood A Pharmaceutical composition with enhanced solubility characteristics
GB201321743D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1916432A1 (de) * 1969-03-31 1970-10-08 Dresden Arzneimittel Verfahren zur Herstellung von Injektionsloesungen von therapeutisch wertvollen Benzodiazepinderivaten und ihren Kombinationen mit anderen Wirkstoffen
IL33774A0 (en) * 1970-01-26 1970-03-22 Abic Ltd A water-soluble composition comprising sulfadimidine and pyrimethamine
DK138974B (da) * 1974-02-19 1978-11-27 Ciba Geigy Ag Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.
DE3006024C2 (de) * 1980-02-18 1983-08-04 Solvon Arzneimittel-Vertriebs- Und Lizenzgesellschaft Mbh, 85011 Burgthann Topisches, Indomethacin enthaltendes Arzneimittel in Salbenform

Also Published As

Publication number Publication date
EP0173729A1 (fr) 1986-03-12
JPS61501566A (ja) 1986-07-31
US4794117A (en) 1988-12-27
OA08170A (fr) 1987-03-31
IT8519873A0 (it) 1985-03-13
KR850700216A (ko) 1985-12-26
EP0173729B1 (fr) 1990-10-17
HU195918B (en) 1988-08-29
IT1200410B (it) 1989-01-18
DE3580140D1 (de) 1990-11-22
NO854461L (no) 1985-11-08
AU4064585A (en) 1985-10-11
NO165626C (no) 1991-03-13
NO165626B (no) 1990-12-03
AU573321B2 (en) 1988-06-02
WO1985004106A1 (fr) 1985-09-26
ATE57472T1 (de) 1990-11-15
KR930000029B1 (ko) 1993-01-06

Similar Documents

Publication Publication Date Title
HUT38263A (en) Process for rendering active substances soluble and production of therapeutic compositions comprising these substances
EP0214647A3 (en) Inclusion complexes of 7-isopropoxy-isoflavone and cyclodextrins, process for their preparation and pharmaceutical preparations containing these complexes
DK0580817T3 (da) Farmaceutisk præparat og fremgangsmåde til fremstilling deraf
IE861813L (en) New Polysaccharide Esters and their Salts
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
MY101847A (en) Composition for solid pharmaceutical preparations of active vitamins d 3 and process for preparation thereof.
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
HU206701B (en) Process for producing substituted flavonoid derivatives and salts and pharmaceutical compositions containing these compounds
HUT51269A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
HUT70150A (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines, pharmaceutical compositions containing them and method for its preparation
PT96400A (pt) Processo de preparacao de composicoes farmaceuticas a base de complexos de acido quinolona-carboxilico-iao metalico-acido
DK0388956T3 (da) Phtalinidderivat, farmaceutisk præparat og anvendelse
AU1176688A (en) Method of treatment comprising transcutaneous administration of prostaglandin E1 derivatives
HU901095D0 (en) Process for producing compound reducing extraction of gastric acid and pharmaceutical preparative containing said compound
EP0382779A4 (en) Tocopherol-based pharmaceutical systems
HU893631D0 (en) Process for producing 1,1-dioxo-cephem-4-carbothiolic acid derivatives and pharmaceutical prepartives containing them as active substance
DK157875C (da) Vandoploeselige rifampicinderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende saadanne forbindelser
MY101535A (en) Pharmaceutical compositions
ATE40687T1 (de) Neue pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
RU95112241A (ru) Способ коррекции побочных эффектов химиолучевой терапии
EP0268267A3 (en) Guanidinomethylbenzoic acid derivatives, compositions containing the same, processes for preparing the same, and the use of the same in the manufacture of medicaments of therapeutic value
ES8406425A1 (es) Procedimiento de fabricacion de un compuesto farmacologico termicamente estable, de dihidrato de oxido amitriptilino
ES2004693A6 (es) Un procedimiento para la preparacion de una composicion farmaceutica solida administrable por via oral, que contiene vinburnina como principio activo.
IE873463L (en) Compositions
HU901875D0 (en) Process for production of galenical preparations providing optimal biological accessibility of 2-hydroxi-5-methyl-laurophenon-oxim as active substance

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee